No black box warning on record for Moxifloxacin Ophthalmic Solution

As of the latest FDA labeling reviewed, Moxifloxacin Ophthalmic Solution (MOXIFLOXACIN OPHTHALMIC SOLUTION) does not carry a black box warning. Standard warnings and precautions still apply — see the full Moxifloxacin Ophthalmic Solution medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions : Hypersensitivity and anaphylaxis have been reported with systemic use of MOXIFLOXACIN. ( 5.1) • Prolonged use : May result in overgrowth of non- susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy. ( 5.2) • Avoid Contact Lens Wear : Patients should not wear contact lenses if th

No black box warning on record for Moxifloxacin Ophthalmic Solution

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions : Hypersensitivity and anaphylaxis have been reported with systemic use of MOXIFLOXACIN. ( 5.1) • Prolonged use : May result in overgrowth of non- susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy. ( 5.2) • Avoid Contact Lens Wear : Patients should not wear contact lenses if th

Moxifloxacin Ophthalmic Solution Black Box Warning

No black box warning on record for Moxifloxacin Ophthalmic Solution

Other warnings & precautions

Moxifloxacin Ophthalmic Solution Black Box Warning

No black box warning on record for Moxifloxacin Ophthalmic Solution

Other warnings & precautions